bioMerieux Aktie

72,85EUR 0,75EUR 1,04%
bioMerieux für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN DE: A2DXZH / ISIN: FR0013280286

<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
<
Aktion
Portfolio
Watchlist
>

Personal

2021 2022 2023 2024 2025
Personal am Ende des Jahres 13 076 13 842 14 651 14 754 15 078
Umsatz pro Mitarbeiter in Mio. EUR 0,26 0,26 0,25 0,27 0,27

Bilanz (in Mio. EUR) - Aktiva

2021 2022 2023 2024 2025
Summe Umlaufvermögen 2 199 2 217 2 205 2 501 2 540
Summe Anlagevermögen 2 418 2 970 3 054 3 269 3 034
Summe Aktiva 4 617 5 187 5 259 5 770 5 575

Bilanz (in Mio. EUR) - Passiva

2021 2022 2023 2024 2025
Summe Fremdkapital 1 442 1 544 1 507 1 559 1 469
Summe Eigenkapital 3 175 3 643 3 752 4 211 4 106
Summe Passiva 4 617 5 187 5 259 5 770 5 575

Adresse

376, chemin de l'Orme, 69280 Marcy l'Etoile
Telefon +33 (4) 78-87-20-00
Fax +33 (4) 78-87-20-90
Internet http://www.biomerieux.com

Management

Alexandre Mérieux
Executive Chairman
Audrey Dauvet
EVP-Legal, Integrity & Public Affairs
Aymeric Fichet
Vice President-Investor Relations
Celine Roger-Dalbert
Executive Vice President-Research & Development
Charles K Cooper
Chief Medical Officer & Executive Vie President
Fanny Letier
Independent Director
François Lacoste
Non-Independent Director
Guillaume Bouhours
Chief Financial Officer & Executive Vice President
Harold Y. H. Boël
Non-Independent Director
Jennifer Zinn
Executive Vice President-Clinical Operations
Marie-Hélène Habert-Dassault
Non-Independent Director
Marie-Paule Kieny
Independent Director
Maud Quillon
Director
Philippe Archinard
Non-Independent Director
Pierre Boulud
Chief Executive Officer
Pierre Charbonnier
EVP-Quality, Manufacturing & Supply Chain
Sylvain Morgeau
Head-Strategic Planning
Valérie Leyldé
Executive VP-Human Resources, Communication & CSR
Viviane Monges
Independent Director
Yasha Mitrotti
Executive Vice President-Industrial Applications